Why this is the number one test of a successful home
During winter, however, the tables turn. As the days grow shorter, we lose almost a third of the 14 hours of daylight that we enjoy in the summer months and, sometimes, experience a corresponding fall in mood.
With scientific evidence increasingly pointing to the detrimental effects artificial light can have on our sleep and mood, it makes sense to light our residential spaces naturally wherever possible. Melbourne-based architect Antony Martin says natural light is the number one element he looks for in a dwelling.
'My most important test of a successful house is when you walk in and there is never a light on during the day because there is well-balanced natural light,' he says.
More than a simple matter of illumination, Martin says natural light has properties that artificial sources struggle to emulate.
'Natural light levels are constantly varying,' he says. 'It is quite imperceptible to the naked eye, but it's very different to artificial light, which is constant throughout the day. There is an emotional attachment that comes with it. You may not be aware of it but the colour of it changes throughout the day.'
At its most basic, the sun appears higher in the sky in summer and lower in winter. For Australians, northern light is the most desirable because it is the most consistent and can be most effectively managed all year round by setting windows and eaves at appropriate levels. The least desirable summer aspect is to the west towards the setting sun which, as it appears lower in the sky, can heat up interiors to uncomfortable levels.
But Martin says it's not without its appeal.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


7NEWS
10 hours ago
- 7NEWS
Sunscreen brands could face reformulation after safety review
Some of our most popular sunscreen brands could be forced to reformulate, after a safety review from the Therapeutic Goods Administration (TGA). The safeguards concern two active ingredients, homosalate and oxybenzone, as well as a by-product called benzophenone. The chemicals help block UV rays, but studies completed overseas suggest they could disrupt hormones when used in very high doses, over a long period of time. Professor Robyn Langham, the TGA's chief medical adviser says the risks are minor. 'The risks that have been identified in some of these studies have been demonstrated only in animals, and only with very high use of product over a prolonged period of time,' Langham said.. 'They can be described as only theoretical, in terms of their risks to humans.' Brands which have products with the active ingredient homosalate include Banana Boat, Nivea, Bondi Sands, Woolworths and Coles-branded sunscreens, and Cancer Council. The Cancer Council says sunscreens available in Australia are safe. 'Cancer Council welcomes developments in evidence, technologies and regulations that improve the regulation of sunscreens,' it said. 'The TGA has confirmed Australians do not need to change their use of sunscreens, and Cancer Council encourages all Australians to use sunscreen as one of the five forms of sun protection when the UV Index is three or above.' One of Brisbane's leading dermatologists, Dr Shobhan Manoharan, expects the TGA to lower the levels of the ingredients allowed in sunscreens. 'The US and Europe have dropped their concentrations on these and I suspect that's the trend we'll see in our local market as well,' Manoharan said. 'If the patient has allergies or sensitive skin or really doesn't want to expose themselves to any of these agents, there are some outstanding physical blockers with zinc or titanium in them, and they can use that as an alternative instead.'


SBS Australia
11 hours ago
- SBS Australia
Nearly 250,000 lives saved from cancer prevention campaigns in Australia, new research finds
Nearly 250,000 lives saved from cancer prevention campaigns in Australia, new research finds Published 9 July 2025, 5:48 am New research has found that cancer prevention campaigns in Australia have saved nearly a quarter of a million lives since the 1950's. The study led by Cancer Council Victoria and the University of Melbourne compared the number of cancer deaths with the predicted number of deaths, if no major cancer control measures had been introduced. The research has also confirmed some forms of cancer are on the rise.

Sydney Morning Herald
13 hours ago
- Sydney Morning Herald
CorWave device: Australian man receives heart implant at St Vincent's Hospital in world first
Jansz said the two-hour surgery was similar to that required for implant devices currently on the market, but its unique design had the potential to deliver enormous benefits for patients. Loading 'This represents a quantum leap in terms of technology,' he said. 'Very sick patients need a lot of blood flowing around their body … this new [implant] has the ability to pump, not only in a pulsatile manner, but in a greater volume.' The device, which effectively bypasses the failing pump action of the left ventricle, is implanted to act as a bridge to transplantation: keeping the patient alive and well until a donor heart becomes available. Smith is currently living in an apartment close to the hospital. He will return to Leeton in a few weeks, where he is looking forward to catching up with his sons and grandchildren – and getting back on the golf course. 'This transition period with the CorWave allows Michael to get better,' Jansz said. 'His kidneys are working normally, his brain and his heart's working well, he's nourished and he's essentially normal. That's a much better situation to go into a transplant with.' Smith was the first of about 20 patients expected to receive the implant as part of a three-year clinical trial testing the device's efficacy. One other patient has since received the implant at St Vincent's. Mimicking the behaviour of a normally functioning heart, the CorWave's oscillating membrane is driven by a single moving part that automatically adjusts blood flow based on what the patient needs – speeding up when the patient is moving and slowing down at times of rest. This represents a major shift from traditional LVADs, which use a rotating impeller to pump a continuous and fixed flow of blood, without generating a pulse. 'The benefit is that it will be able to respond to exercise more efficiently, and it can be put in sync with the heartbeat … the hope is that will translate to better outcomes for patients,' said Professor Chris Hayward, the senior cardiologist at St Vincent's who led Smith's recovery. Around 144,000 people in Australia live with heart failure, the Australian Institute of Health and Welfare estimates. It was the underlying cause of more than 5000 deaths and contributes to more than 170,000 hospitalisations each year. St Vincent's implants about 60 LVADs a year, Hayward said. The procedure is the latest milestone for the globally renowned team at St Vincent's, who in November implanted the world's first totally artificial heart. The research trial has not received Australian government funding, but the device has attracted significant backing from governments and private investors in Europe. Inspired by the movement of marine animals, the undulating membrane technology was conceived by former triple jumper Jean-Baptiste Drevet, who died in 2022. CorWave chief executive Louis de Lillers said the device was the result of more than a decade of research and development by Paris-based engineers and doctors. 'We owe this moment to the trust of the patient, the excellence of the team at St Vincent's, and the perseverance of our team,' he said. Start the day with a summary of the day's most important and interesting stories, analysis and insights. Sign up for our Morning Edition newsletter.